At the news
? MIXEDIMPACT 6/10 CLUSTER filed Feb 19, 2026 at 19:00 ET
A cluster of insider transactions at Ocular Therapeutix (OCUL) over the past week shows mixed activity: one significant open-market purchase by external investor Dr. Richard Lindstrom for $461K, alongside coordinated open-market sales by five insiders including four C-suite executives totaling $256K. The selling is concentrated among senior leadership, while the sole buyer is not an executive officer, suggesting divergent sentiment.
- Dr. Richard L. Lindstrom, MD, purchased 60,229 shares at $7.66 for $461,354.14 on February 20, 2026, in an open-market transaction.
- Four C-suite executives, Pravin Dugel, Peter Kaiser, Jeffrey Heier, Sanjay Nayak, and Nadia Waheed, sold shares between February 20 and February 23, 2026.
- Total insider selling volume: 31,192 shares, valued at $256,374.36 across five transactions.
- All sales were open-market transactions (Form 4 code 'S'), not forced or tax-related dispositions.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access